Trials / Terminated
TerminatedNCT03206879
Fecal ESBL Resurgence During Antibiotic Treatment
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- University Hospital, Akershus · Academic / Other
- Sex
- All
- Age
- 18 Years – 120 Years
- Healthy volunteers
- Not accepted
Summary
Norwegian hospitals are struggling to control spread of extended-spectrum beta-lactamase producing Enterobacteriaceae (ESBL-E) in health care settings. Strict screening and isolation criteria are enforced in hospital, and patients previously infected by ESBL-E are regarded as possible ESBL-E carriers indefinitely. This observational multi-centre cross-sectional study aims to estimate the duration of fecal ESBL-E carriage and to assess the risk of ESBL-E resurgence during hospital stay for patients previously infected by ESBL-E. Through better knowledge of these risk factors, infection control procedures may be better tailored to rhe individual patient.
Conditions
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2018-08-01
- Completion
- 2018-12-01
- First posted
- 2017-07-02
- Last updated
- 2024-02-06
Source: ClinicalTrials.gov record NCT03206879. Inclusion in this directory is not an endorsement.